Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jennifer Martinez

Clinical & Laboratory Dermatological Immunology Miami, FL Physician Assistant

NPI 1184814071 CMS profile 1832447

7700 Sw 104 St, Miami, FL 33156

Open in the dashboard

General payments

$104,337

240 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Martinez of Miami, FL is reported in the CMS Open Payments database as having received $104,337 across 240 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $28,555 47
2024 General $33,247 54
2023 General $39,219 74
2022 General $2,007 36
2021 General $1,308 29

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Martinez
  • Clinical & Laboratory Dermatological Immunology median
  • Middle half of Clinical & Laboratory Dermatological Immunology
  • National median

In program year 2025, general payments to Jennifer Martinez were reported at $28,555. Among 32 Clinical & Laboratory Dermatological Immunology profiles paid that year, the median was $1,254 and the middle half received between $445 and $4,549.

Show as a table
Year Jennifer Martinez Clinical & Laboratory Dermatological Immunology median Middle half National median
2019 $0 $660 $180–$2,230 $163
2020 $0 $432 $119–$1,020 $114
2021 $1,308 $883 $156–$1,571 $132
2022 $2,007 $1,038 $99–$1,992 $149
2023 $39,219 $1,108 $199–$2,848 $160
2024 $33,247 $1,001 $122–$1,882 $164
2025 $28,555 $1,254 $445–$4,549 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Galderma Laboratories, L.P. $98,991 152 payments
  2. Merz North America, Inc. $2,005 21 payments
  3. AbbVie, Inc. $1,186 24 payments
  4. Revance Therapeutics, Inc. $978 9 payments
  5. Allergan Inc. $563 15 payments
  6. LEO Pharma Inc. $203 2 payments
  7. Journey Medical Corporation $199 10 payments
  8. Boehringer Ingelheim Pharmaceuticals, Inc. $84 3 payments
  9. Organon LLC $73 1 payment
  10. E.R. Squibb & Sons, L.L.C. $22 1 payment
  11. Other $34 2 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $94,316 50 payments
  2. Food and Beverage $8,722 170 payments
  3. Consulting Fee $720 1 payment
  4. Travel and Lodging $578 19 payments
Products named General payments · program years 2021–2025
  1. DAXXIFY $978 9 payments
  2. Xeomin $772 9 payments
  3. BOTOX $451 15 payments
  4. AKLIEF $123 1 payment
  5. Qbrexza $97 5 payments
  6. Accutane $97 5 payments
  7. SPEVIGO $84 3 payments
  8. VTAMA $73 1 payment
  9. DYSPORT $27 3 payments
  10. ELIQUIS $22 1 payment
  11. Other $75 5 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

240 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical & Laboratory Dermatological Immunology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record